Tible Olivier Pierre, Riese Florian, Savaskan Egemen, von Gunten Armin
Department of Psychiatry, Service Universitaire de Psychiatrie de l'Age Avancé (SUPAA), Lausanne University Hospital, CH-1008 Prilly, Switzerland.
Department of Geriatric Psychiatry, University Hospital of Psychiatry, Zurich, Switzerland University Research Priority Programme 'Dynamics of Healthy Aging', University of Zurich, Zurich, Switzerland.
Ther Adv Neurol Disord. 2017 Aug;10(8):297-309. doi: 10.1177/1756285617712979. Epub 2017 Jun 19.
Behavioural and psychological symptoms of dementia (BPSD) occur in most patients with dementia. They cause great suffering in patients and caregivers, sometimes more so than the cognitive and functional decline inherent to dementia. The clinical features of BPSD include a wide variety of affective, psychotic and behavioural symptoms and signs. The causes and risk factors for BPSD are multiple and include biological, psychological and environmental variables. Frequently, their combination, rather than any specific factor, explains the occurrence of BPSD in an individual patient. Thus, a sound etiopathogenetic investigation including the patient and the family or care team is essential. The aim is to develop an individualized treatment plan using a therapeutic decision tree modified by the individual and environmental risk profile. Still, treatment may be difficult and challenging. Clinical empiricism often steps in where evidence from controlled studies is lacking. Psychosocial treatment approaches are pivotal for successful treatment of BPSD. Often a combination of different non-pharmacological approaches precedes drug treatment (most of which is off-label). Regular assessments of the treatment plan and any prescriptions must be carried out to detect signs of relapse and to stop any medicines that may have become inappropriate. Even with optimal management, BPSD will not disappear completely in some cases and will remain challenging for all involved parties. This article is a narrative review based closely on the interprofessional Swiss recommendations for the treatment of BPSD. To establish the recommendations, a thorough research of the literature has been carried out. Evidence-based data were provided through searches of Medline, Embase, ISI and Cochrane-Database research. Evidence categories of the World Federation of Biological Societies were used. Additionally, the clinical experience of Swiss medical experts was considered.
大多数痴呆患者会出现痴呆的行为和心理症状(BPSD)。这些症状给患者及其照料者带来巨大痛苦,有时甚至比痴呆本身固有的认知和功能衰退更甚。BPSD的临床特征包括各种各样的情感、精神病性及行为症状和体征。BPSD的病因和风险因素是多方面的,包括生物学、心理学和环境变量。通常,这些因素的综合作用而非任何特定因素,解释了个体患者中BPSD的发生情况。因此,对患者及其家庭或护理团队进行全面的病因学调查至关重要。目的是根据个体和环境风险状况调整治疗决策树,制定个性化的治疗方案。然而,治疗可能困难且具有挑战性。在缺乏对照研究证据时,临床经验主义常常发挥作用。心理社会治疗方法对于成功治疗BPSD至关重要。通常在药物治疗(大多为超说明书用药)之前,先采用不同非药物方法的联合治疗。必须定期评估治疗方案和任何处方,以发现复发迹象并停用可能已变得不合适的药物。即使进行了最佳管理,在某些情况下BPSD也不会完全消失,对所有相关方来说仍然是一个挑战。本文是一篇叙述性综述,紧密基于瑞士跨专业的BPSD治疗建议。为制定这些建议,已对文献进行了全面研究。通过检索Medline、Embase、ISI和Cochrane数据库研究提供了循证数据。采用了世界生物学会联合会的证据类别。此外,还考虑了瑞士医学专家的临床经验。
Ther Adv Neurol Disord. 2017-8
Clin Interv Aging. 2007
Psychogeriatrics. 2024-7
Curr Psychiatry Rep. 2019-7-1
Palliat Care Soc Pract. 2025-1-6
J Alzheimers Dis. 2017
Pharmacol Res. 2017-1
Cochrane Database Syst Rev. 2016-11-16
Front Psychiatry. 2016-9-14
Alzheimer Dis Assoc Disord. 2017